| Cornerstone Hospice 5292 South College Drive, Suite 304, Murray, UT, 84123 | |
| (801) 716-7800 |
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| Name | Cornerstone Hospice |
|---|---|
| Location | 5292 South College Drive, Suite 304, Murray, Utah |
| Hospice ID | 461606 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 170 |
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| NPI Number | 1194155010 |
| Organization Name | Cornerstone Healthcare Inc |
| Address | 5292 S College Dr Murray, Utah, 84123 |
| Phone Number | (801)716-7800 |
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| NPI Number | 1629591003 |
| Organization Name | Exemplar Healthcare, Inc. |
| Address | 1385 W 2200 S Ste 202 West Valley City, Utah, 84119 |
| Phone Number | (801)716-7800 |
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| Home Health Aides | 3.5 |
| Counselors | 0.5 |
| Homemakers | 0.5 |
| Medical Social Workers | 0.5 |
| Physicians | 1 |
| Registered Nurses | 3.5 |
| Total Employees | 9.5 |
|---|
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| Others | 3 |
| Total Volunteers | 3 |
|---|
News Archive
BioEcho Life Sciences announces that the company has recently received CE-mark approval for their EchoLUTION Viral RNA/DNA Swab Kit product line.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
A research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring genetic changes in the HOXB13 and CIP2A genes, aggressiveness of prostate cancer, high risk of developing the disease, and poorer survival rates of patients.
Postmenopausal women who have given birth vaginally do not appear to suffer from urinary incontinence at higher rates than their sisters who have never given birth, according to a University of Rochester Medical Center study published in the December Obstetrics and Gynecology journal.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
› Verified 1 days ago
| Rocky Mountain Hospice Location: 5242 South College Drive, Suite 150, Murray, Utah, 84123 Phone: (801) 716-7800 |
| Harmony Hospice Location: 5650 Green Street, Murray, Utah, 84123 Phone: (801) 716-7800 |
| Encompass Hospice Of Utah Location: 990 West Bellwood Lane, Murray, Utah, 84123 Phone: (801) 716-7800 |
| Superior Hospice Location: 184 East 5900 South, Murray, Utah, 84107 Phone: (801) 716-7800 |